Medtronic drug-coated balloon gets FDA breakthrough status
Published . Updated .
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.
Directly affected
- MDT Medtronic
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.
Source: MedTech Dive
Medtronic (MDT) since “Medtronic drug-coated balloon gets FDA breakthrough status,” compared with the market
Since the first closing price after “Medtronic drug-coated balloon gets FDA breakthrough status,” Medtronic (MDT) is +7.46%. The S&P 500 fund (SPY) is -0.40% over the same days, a +7.85% difference versus the market.
Disclosure records for Medtronic (MDT) within two months of 1 Oct 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 2 days before publication, inside 30 days. The filing is listed beside the story “Medtronic drug-coated balloon gets FDA breakthrough status.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 20 days before publication, inside 30 days. The filing is listed beside the story “Medtronic drug-coated balloon gets FDA breakthrough status.”
- Kevin Hern sell Medtronic (MDT) ($15,001 - $50,000). That is 38 days before publication, inside 60 days. The filing is listed beside the story “Medtronic drug-coated balloon gets FDA breakthrough status.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 59 days before publication, inside 60 days. The filing is listed beside the story “Medtronic drug-coated balloon gets FDA breakthrough status.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Taiwan Strait, seven days against thirty
Taiwan Strait has 49 linked stories in the last 7 days and 49 in the last 30 on the page that also carries “Medtronic drug-coated balloon gets FDA breakthrough status.” The recent pace is rising.
Who gains and who loses around Medtronic (MDT)
Companies carried with this story
- MDT Medtronic
For “Medtronic drug-coated balloon gets FDA breakthrough status,” Medtronic (MDT) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names MEDTRONIC PLC in the headline; GA resolved that company to MDT
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 1 Oct 2026 story “Medtronic drug-coated balloon gets FDA breakthrough status.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “Medtronic drug-coated balloon gets FDA breakthrough status,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence in the 1 Oct 2026 story “Medtronic drug-coated balloon gets FDA breakthrough status.” Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
In “Medtronic drug-coated balloon gets FDA breakthrough status,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “Medtronic drug-coated balloon gets FDA breakthrough status,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
For “Medtronic drug-coated balloon gets FDA breakthrough status,” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
What Taiwan Strait means for Medtronic (MDT)
On 1 Oct 2026, “Medtronic drug-coated balloon gets FDA breakthrough status” is the story that connects Medtronic (MDT) to Taiwan Strait.
For Medtronic (MDT), the reason on file says The reported development directly names MEDTRONIC PLC in the headline; GA resolved that company to MDT
Acadia Healthcare (ACHC) is here too. Its reason reads: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for Medtronic (MDT)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. MDT traded between 85.22 and 96.47 across 20 sessions. The latest close on file is 92.79.
How strong the case is around Medtronic (MDT)
46 out of 100
“Medtronic drug-coated balloon gets FDA breakthrough status” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.